Koninklijke DSM (OTCMKTS:RDSMY)’s stock price reached a new 52-week high during trading on Tuesday . The stock traded as high as $48.75 and last traded at $48.61, with a volume of 20497 shares. The stock had previously closed at $48.47.
Several equities research analysts have recently commented on RDSMY shares. UBS Group restated a “buy” rating on shares of Koninklijke DSM in a research note on Wednesday, July 14th. JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of Koninklijke DSM in a report on Wednesday, July 7th. Barclays raised shares of Koninklijke DSM to an “overweight” rating in a report on Tuesday, May 18th. Zacks Investment Research downgraded shares of Koninklijke DSM from a “hold” rating to a “sell” rating in a report on Wednesday. Finally, Morgan Stanley reaffirmed an “equal weight” rating on shares of Koninklijke DSM in a report on Friday, July 9th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $49.00.
The company’s fifty day moving average price is $46.68. The company has a market capitalization of $35.63 billion, a price-to-earnings ratio of 39.84, a P/E/G ratio of 2.44 and a beta of 0.79.
Koninklijke DSM Company Profile (OTCMKTS:RDSMY)
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments.
Featured Article: Can individual investors take part in an IPO?
Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with MarketBeat.com's FREE daily email newsletter.